On World TB Day, Jay Achar(@dr_jay_a) of Médecins Sans Frontières (@MSFSci) highlights the threat of drug-resistant tuberculosis and calls for improved access to effective new drug regimens. In 2015, the world woke up to the
On International Women’s Day 2016, PLOS Medicine takes a look at some recent articles covering on women’s health topics. Research in our January issue from our Specialty Consulting Editor Alex Tsai and colleagues demonstrates a bidirectional link
Colleagues of the late Anton de Craen remember his remarkable but too brief career.
Peter Hotez and Serap Aksoy, co-editors-in-chief of PLOS NTDs, announce a new collection of research on Mycetoma, an “honorary” NTD. Mycetoma is a serious and debilitating condition that meets all of the criteria we ordinarily
PLOS Neglected Tropical Diseases (PLOS NTDs) co-Editors-in-Chief Peter J Hotez and Serap Aksoy discuss the threat of zika virus spread throughout the Americas and call for zika virus researchers to submit their research to PLOS NTDs
The PLOS Neglected Tropical Diseases team celebrates the 2015 Nobel Prize winners as well as recent victories in onchocerciasis elimination efforts. Unless you regularly work with neglected tropical diseases, onchocerciasis is probably a word you
This week sees a major update to the PLOS Collection “Blue Marble Health: the mismatch between national wealth and population health” with the addition of 50 new papers, including two new editorials published today in
Karin Purshouse (@karinpurshouse), a clinical and academic junior doctor in Oxford, invites you to join the conversation with other early career researchers at the next OpenCon Community Call, this Wednesday, July 29. It is not always
Ahead of the International AIDS Society (IAS) Conference held in 2015 in Vancouver, Canada (July 19-22), Helen Bygrave of MSF discusses her frustrations with the lack of implementation of simple, programmatic strategies for improving HIV
As the Third International Conference on Financing for Development begins in Ethiopia, Áine Markham of Médecins Sans Frontières warns that basing funding decisions on country-level finance indicators could be a step backwards for global health, especially in middle-income countries.